Did you acquire Athira before November 2020?


SAN DIEGO, Oct. 23, 2021 (GLOBE NEWSWIRE) – Johnson Fistel, LLP is investigating potential claims on behalf of Athira Pharma, Inc. (“Athira” or the “Company”) (NASDAQ: ATHA) against certain of its directors and directors.

Recently, a class action lawsuit was filed in federal court against the Company on behalf of the buyers of Athira’s securities from September 18, 2020 and June 17, 2021 (the “Recourse Period”).

The Athira Pharma class action lawsuit alleges that, throughout the Class Period, the Defendants made false and misleading statements and failed to disclose that: (i) research conducted by the President and CEO of ‘Athira Pharma, Defendant Leen Kawas, who formed the Foundation for Product Candidates and Intellectual Property of Athira Pharma, was tainted by Kawas’ scientific misconduct, including manipulation of key data; and (ii) accordingly, the positive statements by the defendants about the activities, operations and prospects of Athira Pharma were materially misleading and omitted material facts necessary to ensure that the statements made were not misleading.

If you are currently a shareholder of Athira, holding shares before November 2020, you may have standing to hold Athira harmless from the alleged prejudice caused by the officers and directors of the Company by making them personally liable. You may also be able to help reform the corporate governance of the Company to avoid future wrongdoing. Click here to join this action

If you would like to know more about the investigation, please contact Senior Analyst Jim Baker ([email protected]) at 619-814-4471. If you are sending an email, please include a phone number.

Additionally, if you are currently a long-term shareholder of Athira, holding shares before November 2020, you can [Click here to join this action]. There is no cost or obligation for you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in class actions between shareholders and derivatives. For more information on the firm and its lawyers, visit http://www.johnsonfistel.com. Lawyer advertising. Past results do not guarantee future results.

[Click here to join this action]

Leave A Reply

Your email address will not be published.